Abstract
The purpose of this study was to determine whether rotational C-arm computed tomography (CT) allows visualization of liver metastases and adds relevant information for radioembolization (RE) treatment planning. Technetium angiography, together with C-arm CT, was performed in 47 patients to determine the feasibility for RE. C-arm CT images were compared with positron emission tomography (PET)/CT images for the detection of liver tumors. The images were also rated according one of the following three categories: (1) images that provide no additional information compared with DSA alone; (2) images that do provide additional information compared with DSA; and (2) images that had an impact on eligibility determination for and planning of the RE procedure. In all patients, 283 FDG-positive liver lesions were detected by PET. In venous contrast-phase CT, 221 (78.1%) and 15 (5.3%) of these lesions were either hypodense or hyperdense, respectively. In C-arm CT, 103 (36.4%) liver lesions were not detectable because they were outside of either the field of view or the contrast-enhanced liver segment. Another 25 (8.8%) and 98 (34.6%) of the liver lesions were either hyperdense or presented primarily as hypodense lesions with a rim enhancement, respectively. With PET/CT as the standard of reference, venous CT and C-arm CT failed to detect 47 (16.6%) and 57 (20.1%) of all liver lesions, respectively. For RE planning, C-arm CT provided no further information, provide some additional information, or had an impact on the procedure in 20 (42.5%), 15 (31.9%) and 12 (25.6%) of patients, respectively. We conclude that C-arm CT may add decisive information in patients scheduled for RE.
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00270-010-9897-8/MediaObjects/270_2010_9897_Fig1_HTML.gif)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00270-010-9897-8/MediaObjects/270_2010_9897_Fig2_HTML.jpg)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00270-010-9897-8/MediaObjects/270_2010_9897_Fig3_HTML.jpg)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00270-010-9897-8/MediaObjects/270_2010_9897_Fig4_HTML.jpg)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00270-010-9897-8/MediaObjects/270_2010_9897_Fig5_HTML.jpg)
Similar content being viewed by others
References
Cianni R, Urigo C, Notarianni E et al (2009) Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases. Cardiovasc Intervent Radiol 32:1179–1186
Bilbao JI, de Martino A, de Luis E et al (2009) Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 32:727–736
Salem R, Lewandowski R, Sato K et al (2007) Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10:12–29
Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278
Gulec SA, Fong Y (2007) Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 142:675–682
Kalender WA, Kyriakou Y (2007) Flat-detector computed tomography (FD-CT). Eur Radiol 17:2767–2779
Welsh JS, Kennedy AS, Thomadsen B (2006) Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73
Lewandowski RJ, Thurston KG, Goin JE et al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16:1641–1651
Salem R, Lewandowski R, Roberts C et al (2004) Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345
Bangash AK, Atassi B, Kaklamani V et al (2007) 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18:621–628
Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935
Haydar AA, Wasan H, Wilson C, Tait P (2010) 90Y radioembolization: embolization of the gastroduodenal artery is not always appropriate. Cardiovasc Intervent Radiol. doi:10.1007/s00270-010-9838-6
Bilbao JI, Garrastachu P, Herráiz MJ et al (2009) Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol. doi:10.1007/s00270-009-9717-1
Heusner TA, Hamami ME, Ertle J et al (2010) Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo [Epub ahead of print]
Louie JD, Kothary N, Kuo WT et al (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20:606–613
Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W (2009) Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol 20:422–424
Ibrahim SM, Lewandowski RJ, Ryu RK et al (2008) Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol 31:1124–1132
Disclosure
Oliver Meissner and Klaus Klingenbeck-Regn are employees of Siemens AG.
Conflict of Interest Statement
For all authors no conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Becker, C., Waggershauser, T., Tiling, R. et al. C-Arm Computed Tomography Compared With Positron Emission Tomography/Computed Tomography for Treatment Planning Before Radioembolization. Cardiovasc Intervent Radiol 34, 550–556 (2011). https://doi.org/10.1007/s00270-010-9897-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9897-8